3 period BE studies, 3 or 6 sequence [Design Issues]

posted by drgunasakaran1  – 2012-06-07 19:48 (5132 d 09:05 ago) – Posting: # 8677
Views: 4,560

Dear Mr John,

❝ I know the old food effect study in the FDA BE guidance (long long back), the one which evaulated Test fed, Ref Fed, test Fast. I think 6 sequence was required.


As per Old FDA's BE Guidance on Single dose, three way cross over, food/fasting study, six sequences should be used.

Quote from the Old FDA’s BE guidance
“A single dose, randomized, three-treatment, three period, six sequence, crossover, limited food effects study, comparing equal doses of the test product administered under fasting conditions with those of test and reference products administered immediately after a standard breakfast”. (Refer page 3 of the Old FDA's BE Guidance)

“Equal number of subjects should be randomly assigned to each of the six dosing sequences” (Refer page 10 of Old FDA's BE Guidance)

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
179 visitors (0 registered, 179 guests [including 23 identified bots]).
Forum time: 04:54 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5